NYSE:AVNSAvanos Medical Stock Price, Forecast & News

Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AVNS shares have increased by 1.1% and is now trading at $29.34. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Avanos Medical.

Avanos Medical is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Avanos Medical.

Avanos Medical Inc (NYSE:AVNS) posted its quarterly earnings results on Wednesday, May, 6th. The company reported $0.16 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.16. The business earned $180.40 million during the quarter, compared to analyst estimates of $175.15 million. Avanos Medical had a negative net margin of 3.07% and a positive return on equity of 4.09%. Avanos Medical's revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.15 earnings per share. View Avanos Medical's earnings history.

7 Wall Street analysts have issued 12 month price objectives for Avanos Medical's shares. Their forecasts range from $30.00 to $48.00. On average, they anticipate Avanos Medical's share price to reach $36.00 in the next twelve months. This suggests a possible upside of 22.7% from the stock's current price. View analysts' price targets for Avanos Medical.

News articles about AVNS stock have trended negative this week, InfoTrie reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Avanos Medical earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Avanos Medical.

Avanos Medical saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 2,370,000 shares, a decline of 13.8% from the May 31st total of 2,750,000 shares. Based on an average trading volume of 430,000 shares, the days-to-cover ratio is presently 5.5 days. Currently, 5.1% of the shares of the company are short sold. View Avanos Medical's Current Options Chain.

Some companies that are related to Avanos Medical include MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Inogen (INGN), Establishment Labs (ESTA), Invacare (IVC), RTI Surgical (RTIX), Sientra (SIEN), Lakeland Industries (LAKE), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Allied Healthcare Products (AHPI), Histogenics (HSGX), Precision Therapeutics (POAI) and Rewalk Robotics (RWLK). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), AT&T (T), Alibaba Group (BABA), CVS Health (CVS), Honeywell International (HON), Procter & Gamble (PG), Verizon Communications (VZ), Home Depot (HD), Johnson & Johnson (JNJ) and Altria Group (MO).

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Avanos Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Confluence Investment Management LLC (1.16%) and Diversified Trust Co (0.03%). Company insiders that own Avanos Medical stock include Gary Blackford, John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View institutional ownership trends for Avanos Medical.

AVNS stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC. View insider buying and selling activity for Avanos Medical.

AVNS stock was purchased by a variety of institutional investors in the last quarter, including Diversified Trust Co. Company insiders that have bought Avanos Medical stock in the last two years include Gary Blackford, John W Wesley, Joseph Fralin Woody, and Steven E Voskuil. View insider buying and selling activity for Avanos Medical.

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVNS stock can currently be purchased for approximately $29.34.

Avanos Medical has a market capitalization of $1.40 billion and generates $697.60 million in revenue each year. The company earns $-45,900,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.

The official website for Avanos Medical is avanos.com.

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]